TB Alternative Assets Ltd. bought a new position in Celestica Inc. (NYSE:CLS - Free Report) TSE: CLS in the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor bought 17,808 shares of the technology company's stock, valued at approximately $1,403,000.
Other hedge funds and other institutional investors have also bought and sold shares of the company. Independent Advisor Alliance boosted its stake in shares of Celestica by 0.3% during the fourth quarter. Independent Advisor Alliance now owns 29,588 shares of the technology company's stock valued at $2,731,000 after purchasing an additional 79 shares during the period. Jones Financial Companies Lllp raised its holdings in shares of Celestica by 4.6% during the fourth quarter. Jones Financial Companies Lllp now owns 2,034 shares of the technology company's stock valued at $188,000 after acquiring an additional 89 shares in the last quarter. CoreCap Advisors LLC raised its holdings in shares of Celestica by 5.4% during the fourth quarter. CoreCap Advisors LLC now owns 1,760 shares of the technology company's stock valued at $162,000 after acquiring an additional 90 shares in the last quarter. Pinpoint Asset Management Ltd raised its holdings in shares of Celestica by 109.6% during the fourth quarter. Pinpoint Asset Management Ltd now owns 348 shares of the technology company's stock valued at $32,000 after acquiring an additional 182 shares in the last quarter. Finally, Bay Rivers Group raised its holdings in shares of Celestica by 1.1% during the first quarter. Bay Rivers Group now owns 19,494 shares of the technology company's stock valued at $1,536,000 after acquiring an additional 215 shares in the last quarter. Hedge funds and other institutional investors own 67.38% of the company's stock.
Celestica Price Performance
CLS opened at $120.78 on Friday. The stock has a fifty day simple moving average of $96.34 and a two-hundred day simple moving average of $99.76. The company has a current ratio of 1.47, a quick ratio of 0.87 and a debt-to-equity ratio of 0.49. The company has a market cap of $13.96 billion, a price-to-earnings ratio of 32.29 and a beta of 1.65. Celestica Inc. has a 12-month low of $40.25 and a 12-month high of $144.27.
Celestica (NYSE:CLS - Get Free Report) TSE: CLS last posted its quarterly earnings data on Thursday, April 24th. The technology company reported $1.20 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.10 by $0.10. The business had revenue of $2.65 billion during the quarter, compared to the consensus estimate of $2.56 billion. Celestica had a return on equity of 23.34% and a net margin of 4.61%. The firm's quarterly revenue was up 19.9% compared to the same quarter last year. During the same quarter in the prior year, the company earned $0.83 earnings per share. Research analysts predict that Celestica Inc. will post 4.35 earnings per share for the current fiscal year.
Wall Street Analyst Weigh In
A number of equities analysts recently commented on the company. CIBC decreased their target price on Celestica from $150.00 to $120.00 and set an "outperformer" rating for the company in a report on Tuesday, April 15th. Barclays decreased their target price on Celestica from $157.00 to $126.00 and set an "overweight" rating for the company in a report on Monday, April 28th. Royal Bank of Canada restated an "outperform" rating and set a $120.00 target price on shares of Celestica in a report on Monday, April 28th. BMO Capital Markets restated an "outperform" rating and set a $130.00 target price (up previously from $118.00) on shares of Celestica in a report on Thursday, May 22nd. Finally, JPMorgan Chase & Co. upped their target price on Celestica from $105.00 to $115.00 and gave the company an "overweight" rating in a report on Monday, April 28th. Two equities research analysts have rated the stock with a hold rating, nine have assigned a buy rating and one has given a strong buy rating to the stock. According to MarketBeat, the company has a consensus rating of "Moderate Buy" and an average price target of $114.82.
Check Out Our Latest Stock Report on Celestica
Celestica Company Profile
(
Free Report)
Celestica Inc provides supply chain solutions in North America, Europe, and Asia. It operates through two segments: Advanced Technology Solutions, and Connectivity & Cloud Solutions. The company offers a range of product manufacturing and related supply chain services, including design and development, new product introduction, engineering services, component sourcing, electronics manufacturing and assembly, testing, complex mechanical assembly, systems integration, precision machining, order fulfillment, logistics, asset management, product licensing, and after-market repair and return services.
See Also
Want to see what other hedge funds are holding CLS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Celestica Inc. (NYSE:CLS - Free Report) TSE: CLS.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Celestica, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Celestica wasn't on the list.
While Celestica currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.